Method of inducing umbilical cord mesenchymal stem cells to differentiate insulin-like cells and an application thereof
AssigneeFangfang Wan
InventorXiaodong Hu
Life of this patent
Estimating the term…
Abstract
A method of inducing umbilical cord mesenchymal stem cells to differentiate insulin-like cells and an application thereof, the invention carries out reasonable culture of purified umbilical cord mesenchymal stem cells by adopting culture medium having different substances, and can efficiently and stably induce them to differentiate into insulin-like cells, and the percentage of insulin-positive cells can reach 80%. The cell preparation prepared after induction of umbilical cord mesenchymal stem cells of the invention can be used for the treatment of clinical diabetic patients with high therapeutic efficacy.
Claims10
A method of inducing umbilical cord mesenchymal stem cells to differentiate insulin-like cells, comprising the following steps:
- S1:
- preparing and obtaining umbilical cord mesenchymal stem cells from umbilical cord;
- S2:
- taking purified umbilical cord mesenchymal stem cells and add them to an α-MEM culture solution containing bFGF, EGF, and 5 wt % human platelet lysate, inducing differentiation of umbilical cord mesenchymal stem cells to nestin-positive progenitor cells NIP;
- S3:
- digesting the cells after the cells are fully spread in the culture bottle, adding an α-MEM culture solution containing glucose and 5 wt % human platelet lysate, and culturing for 2-4 days;
- S4:
- take cells, discard the culture supernatant, add them to an α-MEM culture solution containing ITS-A and 5 wt % human platelet lysate, culture for 3-5 days;
- S5:
- take cells, discard the culture supernatant, add them to an α-MEM culture solution containing 5 wt % human platelet lysate having ITS-A and nicotinamide, and culture for 2-4 days without changing the fluid during the period;
- S6:
- take cells, discard the culture supernatant, add them to an α-MEM culture solution containing 5 wt % human platelet lysate having β-cell regulator, IGF, ITS-A and nicotinamide, and culture for 2-5 days without changing the fluid during the period.
Dependencies are inferred from the claim text.